Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
Description
Vaccines have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) morbidity and mortality, yet emerging variants challenge their effectiveness. The prevailing approach to updating vaccines targets the antibody response, operating
